Clinical Trial: Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07639684) titled 'Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)' on May 28.

Brief Summary: The goal of this clinical trial is to determine whether Endoscopic Sleeve Gastroplasty (ESG)-induced weight loss can improve glycemic outcomes and alter the trajectory toward insulin dependence in adults with obesity and inadequately controlled Type 2 Diabetes (T2D) despite guideline-directed therapy, including Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA)-based agents.

Study Start Date: Feb., 2027

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Mellitus (T2D) Obesity (BMI>30)

Intervention: DEVICE: E...